Invention Grant
- Patent Title: Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase
-
Application No.: US13025674Application Date: 2011-02-11
-
Publication No.: US08354548B2Publication Date: 2013-01-15
- Inventor: Shuanghua Hu , Yazhong Huang , Min Ding , Louis S. Chupak , Xiaofan Zheng , Robert G. Gentles
- Applicant: Shuanghua Hu , Yazhong Huang , Min Ding , Louis S. Chupak , Xiaofan Zheng , Robert G. Gentles
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Pamela A. Mingo; Gary D. Greenblatt
- Main IPC: C07D311/00
- IPC: C07D311/00
Abstract:
The present disclosure is generally directed to compounds that can inhibit DAGLα and/or β activity, compositions comprising such compounds, and methods for inhibiting DAGLα and/or β activity.
Public/Granted literature
- US20110207772A1 Glycine Chroman-6-Sulfonamides for Use as Inhibitors of Diacylglycerol Lipase Public/Granted day:2011-08-25
Information query
